Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

Background: Levodopa-carbidopa intestinal gel (LCIG) improves motor and non-motor symptoms in patients with advanced Parkinson’s disease (aPD). Objective: To present the final 36-month efficacy and safety results from DUOGLOBE (DUOdopa/Duopa in Patients with Advanced Parkinson’s Disease – a GLobal O...

Celý popis

Podrobná bibliografie

Hlavní autoři:	K. Ray Chaudhuri, Norbert Kovács, Francesco E. Pontieri, Jason Aldred, Paul Bourgeois, Thomas L. Davis, Esther Cubo, Marieta Anca-Herschkovitsch, Robert Iansek, Mustafa S. Siddiqui, Mihaela Simu, Lars Bergmann, Mayra Ballina, Pavnit Kukreja, Omar Ladhani, Jia Jia, David G. Standaert
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2023-07-01
Edice:	Journal of Parkinson’s Disease
On-line přístup:	https://doi.org/10.3233/JPD-225105
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!